De Por Vida: A Diabetes Risk Reduction Intervention for Hispanic Women
Culturally Competent Behavioral Intervention for Diabetes Risk Reduction
1 other identifier
interventional
195
0 countries
N/A
Brief Summary
This pragmatic randomized clinical trial will assess the efficacy, cost, and sustainability of a culturally tailored weight-loss program targeting obese Hispanic women with pre-diabetes or T2D. The intervention will be integrated into patient care at a Federally Qualified Health Center serving over 30,000 low-income patients, and will be delivered by trained clinic staff, with minimal support from research staff. After the effectiveness clinical trial, two cohorts of clinic patients will receive the intervention in a sustainability test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable diabetes
Started Jun 2014
Longer than P75 for not_applicable diabetes
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 23, 2014
CompletedFirst Submitted
Initial submission to the registry
April 5, 2017
CompletedFirst Posted
Study publicly available on registry
April 14, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 5, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 5, 2018
CompletedResults Posted
Study results publicly available
September 23, 2020
CompletedSeptember 23, 2020
September 1, 2020
3.7 years
April 5, 2017
February 18, 2020
September 2, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Weight in Kilograms
Comparison of body weight trajectories in kilograms between the intervention and usual-care control groups.
Baseline, 6, 12, and 18 months
Waist Circumference in Centimeters
Comparison of waist circumference trajectories in centimeters between the intervention and usual-care control groups.
Baseline, 6, 12, and 18 months
Secondary Outcomes (9)
Hemoglobin HbA1c % (Transformed Using the Inverse Cube, or 1/HbAlc%^3)
Baseline, 6, 12 and 18 months from enrollment
Fasting Blood Glucose (Fbg; Transformed Using the Inverse Square, or 1/Fbg in mg/dl^2 )
Baseline, 6, 12, and 18 months
Total Cholesterol
Baseline, 6, 12, and 18 months
Number of Fruit Servings Per Day (Transformed Using the Natural Log)
Baseline, 6, 12, and 18 months
Number of Kilocalories
Baseline, 6, 12, and 18 months
- +4 more secondary outcomes
Other Outcomes (2)
Average Program Cost Per Participant
12 months
Recruit Participants for Sustainability Phase
Post-intervention for 12 months
Study Arms (2)
Behavioral
EXPERIMENTAL26 weekly behavioral intervention sessions 6 monthly behavioral intervention sessions Sessions focused on diet, physical activity, behavior change
Enhanced usual care
NO INTERVENTIONPrinted materials
Interventions
A culturally tailored behavioral intervention.
Eligibility Criteria
You may qualify if:
- All participants will be patients who receive their primary medical care at the Virginia Garcia Memorial Health Center (VGMHC)
- Self-identified as Spanish-speaking Latina or Hispanic
- Female
- Age 18 and older
- BMI greater than or equal to 27kg/m2
- Classified as diabetic or prediabetic in the electronic medical record by at least one of the following:
- Fasting plasma glucose ≥ 100
- h post glucose level on the 75-g oral glucose tolerance test ≥ 140-199 mg/dL (7.8-11.0 mmol/L)
- Hemoglobin HBA1c ≥ 5.7
- Diagnosis of diabetes in patient's medical chart
- Diagnosis of prediabetes in patient's medical chart
- Residing in the Portland metropolitan area, and having no plans to leave the area in the next 18 months.
- Willing and able to attend the 26-weekly group meetings and 6 monthly group meetings.
- Willing to accept random assignment to the active intervention or enhanced usual care control.
- Clearance by the patient's VGMHC primary care physician to participate in the intervention.
You may not qualify if:
- Treatment for cancer in the past two years (excluding non-melanoma skin cancers).
- Having conditions that require limitation of physical activity or that would be contraindicated for the DASH (Dietary Approaches to Stop Hypertension) diet patterns.
- Taking weight-loss medication currently or within the past 6 months.
- Current or recent (\< 12 months) pregnancy, breastfeeding, or planning pregnancy in the next 18 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kaiser Permanentelead
- Arizona State Universitycollaborator
Related Publications (1)
Lindberg NM, Vega-Lopez S, LeBlanc ES, Leo MC, Stevens VJ, Gille S, Arias-Gastelum M, Meenan R. Lessons Learned From a Program to Reduce Diabetes Risk Among Low-Income Hispanic Women in a Community Health Clinic. Front Endocrinol (Lausanne). 2021 Jan 8;11:489882. doi: 10.3389/fendo.2020.489882. eCollection 2020.
PMID: 33488511DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Nangel Lindberg
- Organization
- Kaiser Permanente Center for Health Research
Study Officials
- PRINCIPAL INVESTIGATOR
Nangel Lindberg, PhD
Kaiser Permanente
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 5, 2017
First Posted
April 14, 2017
Study Start
June 23, 2014
Primary Completion
March 5, 2018
Study Completion
March 5, 2018
Last Updated
September 23, 2020
Results First Posted
September 23, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share